{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:41:07Z","timestamp":1782877267729,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"FCT","award":["SFRH\/BD\/71021\/2010"],"award-info":[{"award-number":["SFRH\/BD\/71021\/2010"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.metabol.2016.07.007","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T10:04:59Z","timestamp":1469095499000},"page":"1508-1521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Methylsulfonylmethane (MSM), an organosulfur compound, is effective against obesity-induced metabolic disorders in mice"],"prefix":"10.1016","volume":"65","author":[{"given":"In\u00eas","family":"Sousa-Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ju","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Cheol","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana M.","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji A.","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Paula","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Bum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2016.07.007_bb0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMp068177","article-title":"Obesity and diabetes in the developing world\u2014a growing challenge","volume":"356","author":"Hossain","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2016.07.007_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-8587(14)70134-2","article-title":"Obesity, inflammation, and the gut microbiota","volume":"3","author":"Cox","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2016.07.007_bb0015","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.2337\/db14-1488","article-title":"Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases?","volume":"64","author":"Tsai","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2016.07.007_bb0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrendo.2014.169","article-title":"Obesity-driven disruption of haematopoiesis and the bone marrow niche","volume":"10","author":"Adler","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2016.07.007_bb0025","first-page":"438","volume":"8","year":"2003","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.metabol.2016.07.007_bb0030","doi-asserted-by":"crossref","first-page":"11776","DOI":"10.1074\/jbc.C900014200","article-title":"Targeted disruption of ROCK1 causes insulin resistance in vivo","volume":"284","author":"Lee","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2016.07.007_bb0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00044011-200424060-00005","article-title":"Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis","volume":"24","author":"Usha","year":"2004","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.metabol.2016.07.007_bb0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/dmrr.959","article-title":"Taurine supplementation enhances nutrient-induced insulin secretion in pancreatic mice islets","volume":"25","author":"Ribeiro","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.metabol.2016.07.007_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114514004127","article-title":"Betaine alleviates hepatic lipid accumulation via enhancing hepatic lipid export and fatty acid oxidation in rats fed with a high-fat diet","author":"Xu","year":"2015","journal-title":"Br J Nutr"},{"key":"10.1016\/j.metabol.2016.07.007_bb0050","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.molmet.2014.04.010","article-title":"Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels","volume":"3","author":"Dahlhoff","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2016.07.007_bb0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1573399811309030005","article-title":"Role of sulfur containing amino acids as an adjuvant therapy in the prevention of diabetes and its associated complications","volume":"9","author":"Manna","year":"2013","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.metabol.2016.07.007_bb0060","doi-asserted-by":"crossref","first-page":"8334","DOI":"10.3390\/molecules19068334","article-title":"Sulfur amino acids in diet-induced fatty liver: a new perspective based on recent findings","volume":"19","author":"Toohey","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.metabol.2016.07.007_bb0065","first-page":"1","article-title":"Supplementation with methyl donors during lactation to high-fat-sucrose-fed dams protects offspring against liver fat accumulation when consuming an obesogenic diet","author":"Cordero","year":"2014","journal-title":"J Dev Orig Health Dis"},{"key":"10.1016\/j.metabol.2016.07.007_bb0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/039463201302600128","article-title":"Ulcers caused by bullous morphea: successful therapy with N-acetylcysteine and topical wound care","volume":"26","author":"Rosato","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.metabol.2016.07.007_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000276495","article-title":"Accelerated wound healing by S-methylmethionine sulfonium: evidence of dermal fibroblast activation via the ERK1\/2 pathway","volume":"85","author":"Kim","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.metabol.2016.07.007_bb0080","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1248\/bpb.32.651","article-title":"The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophages","volume":"32","author":"Kim","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.metabol.2016.07.007_bb0085","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s10753-013-9645-8","article-title":"Effect of methylsulfonylmethane on paraquat-induced acute lung and liver injury in mice","volume":"36","author":"Amirshahrokhi","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.metabol.2016.07.007_bb0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4254\/wjh.v6.i2.98","article-title":"Methylsulfonylmethane suppresses hepatic tumor development through activation of apoptosis","volume":"27","author":"Kim","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.metabol.2016.07.007_bb0095","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12272-013-0110-x","article-title":"Hepatoprotective effect of methylsulfonylmethane against carbon tetrachloride-induced acute liver injury in rats","volume":"36","author":"Kamel","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.metabol.2016.07.007_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00774-012-0378-9","article-title":"Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal model","volume":"31","author":"Ezaki","year":"2013","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.metabol.2016.07.007_bb0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0394632015622215","article-title":"Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: randomized trial","volume":"29","author":"Notarnicola","year":"2016","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.metabol.2016.07.007_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cyto.2014.11.001","article-title":"Methylsulfonylmethane inhibits NLRP3 inflammasome activation","volume":"71","author":"Ahn","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.metabol.2016.07.007_bb0115","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1172\/JCI73419","article-title":"Hepatic nuclear corepressor 1 regulates cholesterol absorption through a TRbeta1-governed pathway","volume":"124","author":"Astapova","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.07.007_bb0120","doi-asserted-by":"crossref","first-page":"E332","DOI":"10.1152\/ajpendo.00619.2013","article-title":"ROCK1 isoform-specific deletion reveals a role for diet-induced insulin resistance","volume":"306","author":"Lee","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2016.07.007_bb0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cmet.2005.06.011","article-title":"Role of rho-kinase in regulation of insulin action and glucose homeostasis","volume":"2","author":"Furukawa","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2016.07.007_bb0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cmet.2013.12.009","article-title":"The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARgamma, RORs, and rev-erbs","volume":"19","author":"Marciano","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2016.07.007_bb0135","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMcibr1012075","article-title":"Rosiglitazone, PPARgamma, and type 2 diabetes","volume":"363","author":"Kahn","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2016.07.007_bb0140","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2016.07.007_bb0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tem.2012.03.001","article-title":"Thiazolidinediones and PPARgamma agonists: time for a reassessment","volume":"23","author":"Cariou","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2016.07.007_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bone.2015.04.026","article-title":"Effects of diabetes drugs on the skeleton","volume":"82","author":"Meier","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2016.07.007_bb0155","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/eurheartj\/ehv239","article-title":"Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes","volume":"36","author":"Ferrannini","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2016.07.007_bb0160","doi-asserted-by":"crossref","first-page":"9168","DOI":"10.1074\/jbc.M800104200","article-title":"T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2016.07.007_bb0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejphar.2004.04.038","article-title":"Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614","volume":"494","author":"Minoura","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2016.07.007_bb0170","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s12272-009-1511-8","article-title":"PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention","volume":"32","author":"Kim","year":"2009","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.metabol.2016.07.007_bb0175","doi-asserted-by":"crossref","first-page":"E552","DOI":"10.1152\/ajpendo.00569.2011","article-title":"Selective PPARgamma modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice","volume":"302","author":"Lee","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2016.07.007_bb0180","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-Jarvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2016.07.007_bb0185","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.lfs.2011.07.015","article-title":"Dimethyl sulphoxide and dimethyl sulphone are potent inhibitors of IL-6 and IL-8 expression in the human chondrocyte cell line C-28\/I2","volume":"89","author":"Kloesch","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.metabol.2016.07.007_bb0190","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/08923973.2014.956752","article-title":"Methylsulfonylmethane modulates apoptosis of LPS\/IFN-gamma-activated RAW 264.7 macrophage-like cells by targeting p53, Bax, Bcl-2, cytochrome c and PARP proteins","volume":"36","author":"Karabay","year":"2014","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.metabol.2016.07.007_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.taap.2011.03.017","article-title":"The effect of methylsulfonylmethane on the experimental colitis in the rat","volume":"253","author":"Amirshahrokhi","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.metabol.2016.07.007_bb0200","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.joca.2005.10.003","article-title":"Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial","volume":"14","author":"Kim","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.metabol.2016.07.007_bb0205","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s00125-013-2918-9","article-title":"An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy","volume":"56","author":"Fadini","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2016.07.007_bb0210","first-page":"350","article-title":"DNA methylation and hepatic insulin resistance and steatosis","volume":"15","author":"Sookoian","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.metabol.2016.07.007_bb0215","doi-asserted-by":"crossref","first-page":"e0136822","DOI":"10.1371\/journal.pone.0136822","article-title":"Dysregulated hepatic methionine metabolism drives homocysteine elevation in diet-induced nonalcoholic fatty liver disease","volume":"10","author":"Pacana","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2016.07.007_bb0220","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.3390\/nu5093481","article-title":"The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway","volume":"5","author":"Obeid","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2016.07.007_bb0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1665-2681(19)31355-9","article-title":"S-adenosylmethionine metabolism and liver disease","volume":"12","author":"Mato","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.metabol.2016.07.007_bb0230","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/clinchem\/46.2.265","article-title":"Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5'-phosphate concentrations","volume":"46","author":"Melnyk","year":"2000","journal-title":"Clin Chem"},{"issue":"11","key":"10.1016\/j.metabol.2016.07.007_bb0235","doi-asserted-by":"crossref","first-page":"E1491","DOI":"10.1210\/jc.2015-3204","article-title":"Epigenetic alterations in human liver from subjects with type 2 diabetes in parallel with reduced folate levels","volume":"100","author":"Nilsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2016.07.007_bb0240","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/meta.2002.32731","article-title":"The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in Zucker rats","volume":"51","author":"Fonseca","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2016.07.007_bb0245","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.metabol.2009.11.023","article-title":"Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet-induced obesity","volume":"60","author":"Patsch","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2016.07.007_bb0250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mce.2015.01.001","article-title":"High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity","volume":"410","author":"Lecka-Czernik","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2016.07.007_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI72323","article-title":"Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation","volume":"124","author":"Wei","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.07.007_bb0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1476-511X-11-91","article-title":"Impact of an obesogenic diet program on bone densitometry, micro architecture and metabolism in male rat","volume":"11","author":"Gerbaix","year":"2012","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2016.07.007_bb0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1550-2783-8-8","article-title":"Effects of diet type and supplementation of glucosamine, chondroitin, and MSM on body composition, functional status, and markers of health in women with knee osteoarthritis initiating a resistance-based exercise and weight loss program","volume":"8","author":"Magrans-Courtney","year":"2011","journal-title":"J Int Soc Sports Nutr"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:11:13Z","timestamp":1758427873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049516300713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0026049516300713"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2016.07.007","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylsulfonylmethane (MSM), an organosulfur compound, is effective against obesity-induced metabolic disorders in mice","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2016.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}